<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is an imprinting disorder characterized by <z:hpo ids='HP_0001548'>overgrowth</z:hpo>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> predisposition, and <z:e sem="disease" ids="C1705254" disease_type="Disease or Syndrome" abbrv="">congenital malformations</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Approximately 85% of reported BWS cases are <z:hpo ids='HP_0003745'>sporadic</z:hpo>, while the remaining 15% are familial </plain></SENT>
<SENT sid="2" pm="."><plain>BWS is caused by epigenetic or genomic alterations which disrupt genes in one or both of the two imprinted domains on chromosome 11p15.5 </plain></SENT>
<SENT sid="3" pm="."><plain>In each domain, an imprinting center regulates the expression of imprinted genes in cis </plain></SENT>
<SENT sid="4" pm="."><plain>Normally in domain 1, insulin-like growth factor 2 (IGF2) and the untranslated <z:chebi fb="2" ids="33699">mRNA</z:chebi> H19 are monoallelically expressed </plain></SENT>
<SENT sid="5" pm="."><plain>In BWS, increased expression of IGF2 occurs via several mechanisms </plain></SENT>
<SENT sid="6" pm="."><plain>In domain 2, CDKN1C, a growth repressor, and an untranslated <z:chebi fb="40" ids="33697">RNA</z:chebi>, KCNQ1OT1, are normally expressed monoallelically </plain></SENT>
<SENT sid="7" pm="."><plain>In cases of BWS, several mechanisms result in reduced expression of CDKN1C </plain></SENT>
<SENT sid="8" pm="."><plain>Recent reports of BWS cases have identified mutations outside the chromosome 11p15.5 critical region, thereby broadening the challenges in the diagnosis and genetic counseling of individuals and families with BWS </plain></SENT>
</text></document>